Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CLCNKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HTRA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT7P2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101929584 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR1908 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC29A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928389 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KCNS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00665 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DBNDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEGF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on